ADVERTISEMENT
Search

Pharmacy News

Age-related risk of serious falls increases with opioid use

New research published in JAMA Internal Medicine shows that opioid analgesics elevate the likelihood of falls in all adult patients, but the greatest risk is among individuals aged 85 years and older.

FDA warns patients not to use smartwatches or smart rings to measure blood glucose levels

FDA released a safety alert February 21 warning patients about the dangers of smartwatches or smart rings that claim to gauge blood glucose levels without requiring the user to pierce their skin.

Researchers tease out benefit of HPV vaccine based on dose and age group

Findings from a new population-based study found that no matter how many doses of bivalent HPV vaccine were administered, no woman who received the HPV bivalent vaccine at age 12 or 13 years developed invasive cancer later.

CDC seeks to expand University of Michigan’s pharmacist hypertension program across U.S.

According to CDC's recent assessment of the University of Michigan’s Hypertension Pharmacists’ Program (HPP), 66% of patients who consulted with an HPP pharmacist brought their disease under control within 3 months compared with 42% of patients who did not meet with a pharmacist. At 6 months, 69% had their BP under control compared with 56% of nonparticipants.

Low-dose aspirin during pregnancy appears to have no effect on child’s neurodevelopment

Low-dose aspirin during pregnancy is safe, according to a new study published in The American College of Obstetricians and Gynecologists’ Obstetrics and Gynecology. Researchers found that the Bayley Scales of Infant and Toddler Development (Bayley-III) cognitive composite scores indicated no difference when pregnant parents took low-dose aspirin early in pregnancy compared to a placebo. In other words, it neither worsened nor improved a child’s neurodevelopment.

RSS
1345678910Last
ADVERTISEMENT